PESCINI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 4.212
EU - Europa 2.951
AS - Asia 1.918
SA - Sud America 166
Continente sconosciuto - Info sul continente non disponibili 76
AF - Africa 41
OC - Oceania 28
Totale 9.392
Nazione #
US - Stati Uniti d'America 4.128
RU - Federazione Russa 1.011
IT - Italia 636
SG - Singapore 566
CN - Cina 508
PL - Polonia 466
HK - Hong Kong 266
SE - Svezia 207
IE - Irlanda 202
VN - Vietnam 198
KR - Corea 135
BR - Brasile 131
FR - Francia 102
DE - Germania 90
FI - Finlandia 85
GB - Regno Unito 63
IN - India 63
CA - Canada 58
JO - Giordania 36
AU - Australia 28
JP - Giappone 28
TR - Turchia 21
BD - Bangladesh 20
UA - Ucraina 20
AR - Argentina 18
ID - Indonesia 17
ES - Italia 16
NL - Olanda 16
IQ - Iraq 12
CI - Costa d'Avorio 11
MX - Messico 11
ZA - Sudafrica 9
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
BE - Belgio 6
LT - Lituania 6
MA - Marocco 6
CL - Cile 4
CR - Costa Rica 4
EC - Ecuador 4
RO - Romania 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
CO - Colombia 3
EG - Egitto 3
JM - Giamaica 3
MY - Malesia 3
OM - Oman 3
PK - Pakistan 3
PS - Palestinian Territory 3
SN - Senegal 3
VE - Venezuela 3
AL - Albania 2
BH - Bahrain 2
BY - Bielorussia 2
GR - Grecia 2
HN - Honduras 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NG - Nigeria 2
NP - Nepal 2
PH - Filippine 2
PT - Portogallo 2
PY - Paraguay 2
TN - Tunisia 2
TW - Taiwan 2
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BO - Bolivia 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GT - Guatemala 1
HU - Ungheria 1
IR - Iran 1
KN - Saint Kitts e Nevis 1
LB - Libano 1
LY - Libia 1
ML - Mali 1
MN - Mongolia 1
MT - Malta 1
NI - Nicaragua 1
PR - Porto Rico 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.318
Città #
Santa Clara 713
Ashburn 540
Warsaw 466
Singapore 372
Fairfield 348
Chandler 235
Hong Kong 223
Dublin 202
Woodbridge 184
Houston 144
San Jose 143
Seattle 140
Beijing 137
Seoul 135
Cambridge 134
Wilmington 116
Florence 96
Milan 86
Ho Chi Minh City 77
Hefei 75
Altamura 70
Council Bluffs 67
Lawrence 67
Los Angeles 66
Princeton 58
Ann Arbor 57
Moscow 50
Lauterbourg 47
Buffalo 46
The Dalles 46
Jacksonville 44
Rome 44
New York 42
Paris 41
Boston 37
Hanoi 37
Mumbai 36
Munich 36
Melbourne 28
Tokyo 27
Shanghai 26
Turku 24
Medford 23
Helsinki 22
Kent 20
Boardman 19
Dallas 19
London 19
Toronto 19
San Diego 18
Clifton 15
Izmir 14
Orem 13
Bologna 12
Denver 12
Naples 12
São Paulo 12
Abidjan 11
Chicago 11
Jakarta 11
Falls Church 10
Frankfurt am Main 10
Guangzhou 10
Montreal 10
Phoenix 10
Redondo Beach 10
Turin 10
Chennai 9
Johannesburg 9
Norwalk 9
Atlanta 7
Barcelona 7
Da Nang 7
Dong Ket 7
Manchester 7
Verona 7
Yubileyny 7
Andover 6
Brno 6
Brooklyn 6
Dearborn 6
Hillsboro 6
Lappeenranta 6
Palermo 6
Pescara 6
Poplar 6
Stockholm 6
Baghdad 5
Biên Hòa 5
Cagliari 5
Cantù 5
Falkenstein 5
Figino 5
Hải Dương 5
Miano 5
Newark 5
Shenzhen 5
Amsterdam 4
Belo Horizonte 4
Bengaluru 4
Totale 6.112
Nome #
Caratteristiche cliniche, profilo di rischio vascolare e profilo neuropsicologico dei pazienti affetti da leucoencefalopatia micro vascolare sporadica (età-correlata) e geneticamente determinata (CADASIL): Risultati preliminari del MIcrovascular LEukoencephalopaty Study (MILES) 288
CEREBRAL AUTOREGULATION IN THE EARLY STAGES OF CADASIL (CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY) 260
Operationalizing mild cognitive impairment criteria in small vessel disease: The VMCI-Tuscany Study 255
Syncope and Epilepsy coexist in 'possible' and 'drug-resistant' epilepsy (Overlap between Epilepsy and Syncope Study - OESYS) 251
Reperfusion Injury after ischemic Stroke Study (RISKS): Single-centre (Florence, Italy), prospective observational protocol study 250
Role of biological markers for cerebral bleeding risk STRATification in patients with atrial fibrillation on oral anticoagulants for primary or secondary prevention of ischemic stroke (Strat-AF study): Study design and methodology 237
Cerebral microbleeds in patients with mild cognitive impairment and small vessel disease: The Vascular Mild Cognitive Impairment (VMCI)-Tuscany study 224
Diffusion Tensor Imaging to Map Brain Microstructural Changes in CADASIL 208
Circulating Biomarkers in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Patients 207
APOE ε 2 is associated with white matter hyperintensity volume in CADASIL 206
Can CHA2DS2-VASc and HAS-BLED Foresee the Presence of Cerebral Microbleeds, Lacunar and Non-Lacunar Infarcts in Elderly Patients With Atrial Fibrillation? Data From Strat-AF Study 205
CADASIL in central Italy: A retrospective clinical and genetic study in 229 patients 204
Acetazolamide for the prophylaxis of migraine in CADASIL: a preliminary experience. 198
Bone marrow-derived progenitor cells in cerebral autosomal dominantarteriopathy with subcortical infarcts and leukoencephalopathy 196
The serum metabolomic profiles of atrial fibrillation patients treated with direct oral anticoagulants or vitamin K antagonists 193
Longitudinal changes in MoCA performances in patients with mild cognitive impairment and small vessel disease. Results from the VMCI-Tuscany Study 187
Mild cognitive impairment etiologic subtyping using pragmatic and conventional criteria: preliminary experience in the Florence VAS-COG clinic. 187
Intravenous thrombolysis in CADASIL: report of two cases and a systematic review 183
European Stroke Organisation Conference: Abstracts 183
White matter microstructural damage and depressive symptoms in patients with mild cognitive impairment and cerebral small vessel disease: the VMCI-Tuscany Study. 181
The CADASIL scale: a screening tool to select patients for NOTCH3 gene analysis 179
A pathogenic mutation on exon 21 of the NOTCH3 gene causing CADASIL in an octogenarian paucisymptomatic patient 179
Association Between Motor and Cognitive Performances in Elderly With Atrial Fibrillation: Strat-AF Study 179
Cerebellar arteriovenous malformation and vertebral artery aneurysm in a CADASIL patient 176
Blood–brain barrier leakage and hemorrhagic transformation: The Reperfusion Injury in Ischemic StroKe (RISK) study 174
A pathogenic mutation on exon 21 of the NOTCH3 gene causing CADASIL in an octogenarian paucisymptomatic patient 169
Cognitive phenotypes and factors associated with cognitive decline in a cohort of older patients with atrial fibrillation: The Strat-AF study 168
Application of the DSM-5 Criteria for Major Neurocognitive Disorder to Vascular MCI Patients 165
Influence of vascular risk factors and neuropsychological profile on functional performances in CADASIL: results from the MIcrovascular LEukoencephalopathy Study (MILES). 165
Coronary microvascular function is impaired in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 165
The contribution of cerebrospinal fluid oligoclonal band sto the early diagnosis of multiple sclerosis 163
Differential diagnosis between epilepsy and syncope. The Oesys study (overlapping between epilepsy and syncope study): Preliminary results 163
Thrombophilic risk factors and unusual clinical features in three Italian CADASIL patients 160
Familial cerebral cavernous malformation: report of a further Italian family 157
Ischemic stroke during cisplatin-based chemotherapy for testicular germ celltumor: case report and review of the literature. 154
High lipoprotein(a) serum levels in three CADASIL families. 153
Association of nimodipine and choline alphoscerate in the treatment of cognitive impairment in patients with cerebral small vessel disease: study protocol for a randomized placebo-controlled trial—the CONIVaD trial 151
Stroke recurrence in an elderly CADASIL patient on aspirin discontinuation due to severe auto-immune thrombocytopenia 150
Cerebral hemorrhages in CADASIL: report of four cases and a brief review. 149
Functional Magnetic Resonance Imaging of Inhibitory Control Reveals Decreased Blood Oxygen Level Dependent Effect in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy 146
Cardiac calcified amorphous tumor as a rare cause of ischemic stroke: Clinical case 142
Altered Regional Brain Homogeneity of BOLD Signal in CADASIL: A Resting State fMRI Study 138
Detection of subclinical atrial fibrillation after cryptogenic stroke using implantable cardiac monitors 137
Efficacy and Safety of the Association of Nimodipine and Choline Alphoscerate in the Treatment of Cognitive Impairment in Patients with Cerebral Small Vessel Disease. The CONIVaD Trial 136
Letter by Pescini et al Regarding Article, "Peripheral Artery Disease as a Manifestation of Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) and Practical Implications". 131
Postpartum psychiatric disturbances as an unrecognized onset of CADASIL. 130
Psychiatric disturbances in CADASIL: a brief review 129
Exploring differences in Cerebral Small Vessel Disease: a comparative analysis of clinical, radiological and cognitive features of Cerebral Amyloid Angiopathy and Deep Perforator Arteriopathy 127
Mutation screening of HTRA1 gene in NOTCH3-negative patients with cerebral small vessel disease 123
High frequency of exon 10 mutations in the NOTCH3 gene in Italian CADASIL families: phenotypic peculiarities. 120
Response to letter regarding article, “The cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy scale. A screening tool to select patients for NOTCH3 gene analysis” 116
Effects of sapropterin on endothelium-dependent vasodilation in patients with CADASIL: a randomized controlled trial 114
First report of a Romanian CADASIL patient following immigration to Italy 110
Genome-wide genotyping demonstrates a polygenic risk score associated with white matter hyperintensity volume in CADASIL 104
Disease Severity Staging System for NOTCH3-Associated Small Vessel Disease, Including CADASIL 24
Pleiotropic Effects of Oral Anticoagulant Therapy: Is There a Difference Between VKAs and DOACs? 23
A single-blind randomized trial on the efficacy of telerehabilitation in post-stroke cognitive impairment. CIPS-TER study: rationale, design and methodology 20
Totale 9.392
Categoria #
all - tutte 27.882
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.882


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022284 0 24 12 8 5 27 11 24 11 19 44 99
2022/2023994 91 227 42 64 71 164 122 48 104 2 46 13
2023/2024407 11 40 58 19 40 51 14 99 6 22 25 22
2024/20252.560 100 321 161 421 620 300 43 183 110 82 90 129
2025/20262.908 369 401 185 242 386 103 338 134 157 204 79 310
2026/2027153 91 62 0 0 0 0 0 0 0 0 0 0
Totale 9.392